Tag Archives: glucagon receptor agonist

Peptide Guides

Retatrutide vs Tirzepatide: Which Multi-Agonist Leads Metabolic Research in 2026?

Posted on by OzPEP ozpep.com
Retatrutide vs tirzepatide

Key Takeaways The race to develop the most effective metabolic research peptide has intensified. Two compounds have pulled ahead of the pack: Retatrutide (Eli Lilly’s triple agonist) and Tirzepatide (Eli Lilly’s dual agonist, already marketed as Mounjaro/Zepbound). For Australian researchers designing metabolic protocols, understanding the precise differences between these two powerhouses isn’t optional — it’s […]

Continue reading →
Peptide Guides

Retatrutide Australia 2026: Complete Research Guide, Dosage Protocols & Cost Breakdown

Posted on by OzPEP ozpep.com
Retatrutide Australia 2026: Complete Research Guide, Dosage Protocols & Cost Breakdown

Key Takeaways Retatrutide — also known by its developmental code LY3437943 — has rapidly emerged as the most promising compound in modern metabolic research. In Phase 2 trials, it achieved something no other pharmacological agent has: a 24.2% mean weight loss in participants. That’s not a typo. For Australian researchers, biohackers and peptide scientists, understanding […]

Continue reading →